EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 2Y Ago
-128.1x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-240.11M-90.2%
2024$-126.23M-6832.1%
2023$1.88M+102.9%
2022$-65.00M-29.8%
2021$-50.10M-247.1%
2020$-14.44M+74.5%
2019$-56.70M-158.8%
2018$-21.91M-6.9%
2017$-20.49M-25.6%
2016$-16.32M-